Theliatinib (HMPL-309)
Theliatinib (HMPL-309) is a highly potent EGFR inhibitor with Ki value of 0.05 nM against the wild type EGFR and IC50 values of 3 nM and 22 nM against EGFR and EGFR T790M/L858R mutant. It demonstrats 50 fold greater selectivity for EGFR compared to 72 other kinases.
Trivial name | N/A |
Catalog Number | S8584 |
Molecular Formula | C25H26N6O2 |
CAS# | 1353644-70-8 |
Inchi | InChI=1S/C25H26N6O2/c1-4-16-6-5-7-18(10-16)28-24-19-11-21(23(33-3)12-20(19)26-15-27-24)29-25(32)31-13-17-8-9-30(2)22(17)14-31/h1,5-7,10-12,15,17,22H,8-9,13-14H2,2-3H3,(H,29,32)(H,26,27,28)/t17-,22+/m1 /s1 |
Inchi Key | FSXCKIBROURMFT-VGSWGCGISA-N |
SMILES | COC1=C(NC(=O)N2CC3CCN(C)C3C2)C=C4C(=NC=NC4=C1)NC5=CC(=CC=C5)C#C |
Size | 5mg |
Supplier Page | http://www.selleckchem.com/products/theliatinib-hmpl-309.html |
Additional Information | https://file.selleck.cn/downloads/struct/theliatinib-hmpl-309-chemical-structure-s8584.gif |